Next report date
Report period
Q1 2024
EPS estimate
−0.68USD
Revenue estimate
—
−26.08USD
−34.36 MUSD
4.70 M
About CalciMedica, Inc.
Sector
Industry
CEO
Rachel Anne Leheny
Website
Headquarters
La Jolla
Employees (FY)
14
Founded
2007
FIGI
BBG0088HHJ97
CalciMedica, Inc. operates as a biopharmaceutical company. It focuses on developing therapies for life-threatening inflammatory diseases. The firm's product candidate Auxora helps in treating acute pancreatitis and asparaginase-associated pancreatitis. The company was founded by Kenneth A. Stauderman and Gonul Velicelebi in 2007 and is headquartered in La Jolla, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CALC is 5.29 USD — it has decreased by 3.64% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange CalciMedica, Inc. stocks are traded under the ticker CALC.
CalciMedica, Inc. is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
CALC stock is 14.86% volatile and has beta coefficient of 3.16. Check out the list of the most volatile stocks — is CalciMedica, Inc. there?
CALC earnings for the last quarter are −0.82 USD per share, whereas the estimation was −1.14 USD resulting in a 28.07% surprise. The estimated earnings for the next quarter are −0.87 USD per share. See more details about CalciMedica, Inc. earnings.
Yes, you can track CalciMedica, Inc. financials in yearly and quarterly reports right on TradingView.
CALC stock has risen by 26.86% compared to the previous week, the month change is a 29.02% rise, over the last year CalciMedica, Inc. has showed a 51.14% increase.
CALC net income for the last quarter is −4.15 M USD, while the quarter before that showed −4.62 M USD of net income which accounts for 10.24% change. Track more CalciMedica, Inc. financial stats to get the full picture.
Today CalciMedica, Inc. has the market capitalization of 58.96 M, it has increased by 4.03% over the last week.
No, CALC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CALC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CalciMedica, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 26, 2024, the company has 14.00 employees. See our rating of the largest employees — is CalciMedica, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CalciMedica, Inc. technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CalciMedica, Inc. stock shows the strong buy signal. See more of CalciMedica, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on CalciMedica, Inc. future price: according to them, CALC price has a max estimate of 22.00 USD and a min estimate of 9.50 USD. Read a more detailed CalciMedica, Inc. forecast: see what analysts think of CalciMedica, Inc. and suggest that you do with its stocks.